Physician Wealth Advisors’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.1K Buy
59
+8
+16% +$4.62K ﹤0.01% 552
2026
Q1
$34.8K Buy
51
+8
+19% +$5.53K ﹤0.01% 486
2025
Q4
$24.5K Sell
43
-5
-10% -$2.9K ﹤0.01% 537
2025
Q3
$29.2K Buy
48
+32
+200% +$18.1K ﹤0.01% 490
2025
Q2
$8K Buy
16
+10
+167% +$4.92K ﹤0.01% 686
2025
Q1
$3.07K Sell
6
-59
-91% -$28.2K ﹤0.01% 807
2024
Q4
$30.5K Buy
+65
New +$32.7K 0.01% 423

Other funds holding NOC

Physician Wealth Advisors's NOC Position: Q2 2026 in Review

Physician Wealth Advisors increased its Northrop Grumman (NOC) stake by 16% in Q2 2026, buying an estimated $4.62K and bringing the position to 59 shares worth $30.1K. The position accounts for ﹤0.01% of the portfolio, ranked #552.

Physician Wealth Advisors first reported a position in NOC in Q4 2024 and has held it in 7 quarters since. The position peaked at $34.8K in Q1 2026. 1,812 funds tracked by Wall St. Rank hold NOC as of Q2 2026.

  • Physician Wealth Advisors held 59 shares of Northrop Grumman worth $30.1K as of Q2 2026.
  • Physician Wealth Advisors bought 8 Northrop Grumman shares in Q2 2026, an estimated $4.62K.
  • Northrop Grumman made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #552 holding.
  • Physician Wealth Advisors first reported a position in Northrop Grumman in Q4 2024 and has held it in 7 quarters since.
  • Physician Wealth Advisors's Northrop Grumman position peaked at $34.8K in Q1 2026.
  • 1,812 funds tracked by Wall St. Rank held Northrop Grumman as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.